Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial
Nawal Al Kaabi, Yun Yang, Jing Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines
Fatemeh Bayani, Negin Safaei Hashkavaei, Sareh Arjmand, et al.
Progress in Biophysics and Molecular Biology (2023) Vol. 178, pp. 32-49
Open Access | Times Cited: 49
PastoCovac and PastoCovac Plus as protein subunit COVID-19 vaccines led to great humoral immune responses in BBIP-CorV immunized individuals
Amitis Ramezani, Rahim Sorouri, Saiedeh Haji‐Maghsoudi, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 21
CHO cells for virus-like particle and subunit vaccine manufacturing
Zalma V. Sanchez-Martinez, Sergio P. Alpuche-Lazcano, Matthew Stuible, et al.
Vaccine (2024) Vol. 42, Iss. 10, pp. 2530-2542
Open Access | Times Cited: 6
Safety, immunogenicity and protective effect of sequential vaccination with inactivated and recombinant protein COVID-19 vaccine in the elderly: a prospective longitudinal study
Hong-Hong Liu, Yunbo Xie, Bao-Peng Yang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Adjuvant-dependent impact of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus
Jacob A. Dillard, Sharon Taft-Benz, Audrey C. Knight, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants
Jing Zhang, Zi Bo Han, Yu Liang, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 21
Structural and computational design of a SARS-CoV-2 spike antigen with improved expression and immunogenicity
James A. Williams, Marco Biancucci, Laura N. Lessen, et al.
Science Advances (2023) Vol. 9, Iss. 23
Open Access | Times Cited: 13
A Comparative Study of Immunogenicity, Antibody Persistence, and Safety of Three Different COVID-19 Boosters between Individuals with Comorbidities and the Normal Population
Fatemeh Ashrafian, Fahimeh Bagheri Amiri, Anahita Bavand, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1376-1376
Open Access | Times Cited: 13
Effect of homologous or heterologous vaccine booster over two initial doses of inactivated COVID-19 vaccine
Viravarn Luvira, Punnee Pitisuttithum
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 283-293
Open Access | Times Cited: 4
COVID-19 vaccines: A comprehensive review of safety and efficacy
Zhipeng Yan, Ming Yang, Ching‐Lung Lai
Elsevier eBooks (2025), pp. 685-777
Closed Access
Immunological effectiveness of the booster Soberana Plus vaccine (FINLAY-FR-1A)
K. S. Korsak, Е. В. Воропаев, О. В. Осипкина, et al.
Health and Ecology Issues (2025) Vol. 21, Iss. 4, pp. 26-36
Closed Access
Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant
Ioannis Sitaras, Henning Jacobsen, Melissa M. Higdon, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 16
Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trial
Saeed Erfanpoor, Seyed Reza Banihashemi, Ladan Mokhbaeralsafa, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Designing an integrated sustainable-resilient mix-and-match vaccine supply chain network
Ali Jahed, Seyyed Mohammad Hadji Molana, Reza Tavakkoli‐Moghaddam, et al.
Annals of Operations Research (2024)
Closed Access | Times Cited: 3
Effects of inactivated SARS‐CoV‐2 vaccination on male fertility: A retrospective cohort study
Yehao Dong, Xiaoyun Li, Zewu Li, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Closed Access | Times Cited: 13
COVID-19 vaccines and a perspective on Africa
Alberto Mantovani, María Rescigno, Guido Forni, et al.
Trends in Immunology (2023) Vol. 44, Iss. 3, pp. 172-187
Open Access | Times Cited: 8
An overview of protein-based SARS-CoV-2 vaccines
Yogesh R. Suryawanshi
Vaccine (2023) Vol. 41, Iss. 42, pp. 6174-6193
Closed Access | Times Cited: 8
COVID-19 Vaccines—All You Want to Know
Akira Shishido, Ashley H. Barnes, Shivakumar Narayanan, et al.
Seminars in Respiratory and Critical Care Medicine (2023) Vol. 44, Iss. 01, pp. 143-172
Closed Access | Times Cited: 7
Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial
Nawal Al Kaabi, Yun Yang, Yu Liang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 4
Novel receptor, mutation, vaccine, and establishment of coping mode for SARS-CoV-2: current status and future
Zhaomu Zeng, Xiuchao Geng, Xichao Wen, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 4
Deciphering the rule of antigen-antibody amino acid interaction
Min Jiang, Changyin Fang, Yongping Ma
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Safety, Immunogenicity, and Antibody Persistence of COVID-19 Boosters in BBIP-CorV Immunized Individuals with Comorbidities
Fatemeh Ashrafian, Fahimeh Bagheri Amiri, Anahita Bavand, et al.
(2023)
Open Access | Times Cited: 2
Maintenance of Long-Term Effective Humoral Immune Response in Patients with COVID-19 with Homologous or Heterologous Booster Vaccines: A Retrospective Study
Xin Zhang, Li Li, Yongmei Liu, et al.
Viral Immunology (2024) Vol. 37, Iss. 10, pp. 480-488
Closed Access
Safety and immunogenicity of a broad-spectrum mosaic vaccine as a booster dose against SARS-CoV-2 Omicron and other circulating variants
Nawal Al Kaabi, Yun Yang, Yu Liang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Structural and Computational Design of a SARS-2 Spike Antigen with Increased Receptor Binding Domain Exposure and Improved Immunogenicity
James A. Williams, Marco Biancucci, Laura N. Lessen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top